Alves-Pimenta Sofia, Félix Luís, Colaço Bruno, Oliveira Paula A, Venâncio Carlos
Department of Animal Science, University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.
Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.
Methods Mol Biol. 2018;1797:33-59. doi: 10.1007/978-1-4939-7883-0_2.
Developmental toxicology is a constantly evolving research field which needs to attend to a complex underlying regulatory network. Before entering the market new substances have to be tested for toxic effects on reproduction and development in order to ensure human health and environmental safety. Traditional in vivo mammalian models represent more adequately the intricacy of human development and provide an assessment of the interaction of chemicals on the reproductive system. However, in the last years, the main goal is to reduce the use of vertebrate animals, using those only as last resort. Consequently, the interest in the development and validation of a battery of alternative tests able to cover the various aspects of the reproductive cycle has increased. Reproductive toxicity is probably the most difficult endpoint to be replaced by alternative assays, since it should provide information on mechanisms interactions essential for female and male fertility, and also knowledge on the development of a new human being during its prenatal life. This complexity explains the slow progress in implementing alternatives for reproductive toxicity safety assessments. Alternative test methods may be based on in vitro systems and non-mammalian animal models. Many biological processes have been successfully implemented using in vitro models, opening the possibility to study the interference of teratogenic compounds using these models. Their validation and implementation have lagged behind, in part because of difficulties in establishing their predictability. Nevertheless, the advance toward the process of validation is crucial for a strategy aiming to replace and reduce the use of living animals. Based on the present state of the art, it is not probable that such testing strategies will completely replace the need to assess reproductive toxicity in vivo in the near future, but they contribute to reduce the animal testing and provide important information. In this chapter the approved guidelines for standard methods and alternative methods according to their regulatory and scientific status are enumerated and described.
发育毒理学是一个不断发展的研究领域,需要关注复杂的潜在调控网络。新物质在进入市场之前必须进行生殖和发育毒性测试,以确保人类健康和环境安全。传统的体内哺乳动物模型更充分地体现了人类发育的复杂性,并能评估化学物质对生殖系统的相互作用。然而,近年来,主要目标是减少脊椎动物的使用,仅在万不得已时才使用。因此,人们对开发和验证一系列能够涵盖生殖周期各个方面的替代测试的兴趣增加了。生殖毒性可能是最难被替代试验取代的终点指标,因为它需要提供有关对雌性和雄性生育至关重要的机制相互作用的信息,以及有关新生命在产前发育的知识。这种复杂性解释了在实施生殖毒性安全评估替代方法方面进展缓慢的原因。替代测试方法可能基于体外系统和非哺乳动物动物模型。许多生物过程已成功使用体外模型实现,这为使用这些模型研究致畸化合物的干扰提供了可能性。它们的验证和实施滞后,部分原因是难以确定其可预测性。然而,朝着验证过程迈进对于旨在替代和减少活体动物使用的战略至关重要。基于目前的技术水平,在不久的将来,此类测试策略不太可能完全取代体内评估生殖毒性的需求,但它们有助于减少动物试验并提供重要信息。在本章中,将根据其监管和科学地位列举并描述标准方法和替代方法的批准指南。